Distributive Justice and the New Medicine
Show Less

Distributive Justice and the New Medicine

George P. Smith II

The author begins by examining various economic constructs as aids for achieving a fair and equitable delivery of health care services. He then assesses their level of practical application and evaluates the costs and benefits to society of pursuing the development and use of the ‘New Medicine’. The book ends with a case study of organ and tissue transplantation that illustrates the implementation of distributive justice. The author concludes that as long as clinical medicine maintains its focus on healing and alleviating suffering among patients, a point of equilibrium will be reached that advances the common good.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 3: The new medicine and scientific research

George P. Smith II


3. The new medicine and scientific research INTRODUCTION Substantial scientific evidence indicates man’s genetic inheritance acts as a major influence not only upon his behavior but also upon his health.1 In the United States, for example, it is estimated that 1 out of every 33 babies is born with a discernible genetic deficiency which in turn accounts for more than 20 percent of all infant deaths.2 Of all chronic diseases, between 20 and 25 percent are predominantly genetic in origin.3 Down syndrome, for example, is a genetic condition affecting nearly 1 in 800 babies.4 At least half of the hospital beds in America have been occupied by patients whose incapacities were known to be of a genetic origin.5 Because modern medicine can alleviate the symptoms of some genetic diseases through sophisticated treatment, many who are afflicted and who would not have survived in the past now survive. Medicine is unable to cure genetic defects ex utero,6 but has been astute in identifying over 4000 inherited disorders.7 The “new medicine” attempts—largely through genetic diagnostics, screening and manipulation—to alleviate the heartbreak of genetic suffering and thereby attack genetic disease. Unmistakenly, this type of medicine has a eugenic character; but this, as will be seen, is by no means an overpowering negative.8 Considerable research into techniques for perfecting genetic engineering has been undertaken in an attempt to develop new treatment for individuals with inherited diseases.9 Under the rubric of the “New Biology,” scientists...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.